SCHEMBL1377359

SCHEMBL1377359

NC(=O)Nc1cccc(CC(c2ccc(F)cc2)(c2cccnc2)c2cccnc2)n1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 4/20 0.40
LMNA P02545 1/20 0.40
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
PTGER2 P43116 4/20 0.38
GPR55 Q9Y2T6 1/20 0.37
CYP19A1 P11511 1/20 0.35
SCN9A Q15858 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3810171 0.89 CYP1A2 (0.41) LMNACYP11B1CYP11B2PTGER2GPR55
SCHEMBL3816028 0.87 PTGER2 (0.39) LMNACYP11B1CYP11B2PTGER2CYP19A1
SCHEMBL1381538 0.84 GRM2 (0.39) CYP11B1CYP11B2CYP19A1SCN9A
SCHEMBL1379054 0.82 NR3C2 (0.40) NR3C2LMNAPTGER2SCN9A
SCHEMBL1378598 0.81 KCNA5 (0.51) LMNAPTGER2GPR55SCN9A
SCHEMBL1377502 0.79 KCNH3 (0.39) CYP11B1CYP11B2GPR55CYP19A1
SCHEMBL1379275 0.79 PTGER2 (0.38) PTGER2GPR55
SCHEMBL3812181 0.79 LMNA (0.37) LMNACYP11B1CYP11B2PTGER2GPR55
SCHEMBL3809308 0.77 CYP19A1 (0.38) CYP11B1CYP11B2GPR55CYP19A1
SCHEMBL1382204 0.75 SMN1; SMN2 (0.42) LMNACYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719744-B2 2011-07-06 JP claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP claimed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP claimed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed